RFK Jr. Just Supercharged These 2 Biotech Penny Stocks
SGMO and EDIT are set to benefit from RFK Jr.’s plans to fast-track the review of drugs targeting rare diseases.
Barchart ·
Get all your news in one place.
100's of premium titles.
One app.
Start reading
One app.
Get all your news in one place.
100's of premium titles. One news app.
FOUND: Sgmo - What They Never Told You
3 Penny Stocks With 66% to 245% Upside Potential
Investing in these penny stocks could unlock extraordinary gains, with expected returns of up to 245%. Here are three analyst-recommended stocks from in-demand industries, all with significant upside potential.
Barchart ·
Sangamo Therapeutics's Earnings: A Preview
Sangamo Therapeutics (NASDAQ:SGMO) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement.
Analysts estimate that Sangamo Therapeutics will report an earnings per share (EPS) of $-0.31.
Benzinga ·
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Coverage From
Benzinga
Barchart
Organisations
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Topics
Read news from The Economist, FT, and more,
with one subscription
with one subscription
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.
100+ trusted global sources.
